foxo4-dri senolytic human trial 2024 Class II senolytics inhibit survival pathways elicited by senescent Full article: Targeting Cellular Senescence
Description
Multiple Sclerosis MS is a chronic inflammatory disease of the CNS, characterized by demyelination, inflammation, and progressive neurodegeneration
Ingredients that are on the FDA negative list also cannot be used as active ingredients for human compounding unless a specific route or dose is allowed on the list, as is the case with oral doses of diethylstilbestrol under 25 mg
Giving a large IV dose too quickly has been linked to dizziness or feeling hot
Healthier narratives on wellbeing are needed
